Ordered by composite index (descending). Higher values indicate more intensive citation.
| # | Reference | Year | Mentions | Breadth | Sec. Wtd | Share | Composite | Main % |
|---|---|---|---|---|---|---|---|---|
| 1 | Hahn J, Hirano K, Karlan D | 2011 | 7 | 4 | 10.5 | 0.029 | 1.000 | 100% |
| 2 | Antos A, Grover V, Szepesvari C | 2010 | 8 | 7 | 12.0 | 0.033 | 1.000 | 100% |
| 3 | Carpentier A, Munos R | 2011 | 9 | 8 | 14.0 | 0.037 | 1.000 | 100% |
| 4 | Grover V | 2009 | 8 | 7 | 12.0 | 0.033 | 1.000 | 100% |
| 5 | Chen Y, Lu J | 2025 | 8 | 6 | 13.0 | 0.033 | 1.000 | 100% |
| 6 | Khamaru K, Zhang CH | 2024 | 9 | 6 | 15.0 | 0.037 | 1.000 | 100% |
| 7 | Xiong R, Athey S, Bayati M, Imbens GW | 2019 | 6 | 4 | 9.0 | 0.025 | 1.000 | 100% |
| 8 | Lattimore T, Szepesvari C | 2020 | 4 | 4 | 6.5 | 0.017 | 0.928 | 100% |
| 9 | Melfi VF, Page C | 2000 | 4 | 3 | 6.5 | 0.017 | 0.928 | 100% |
| 10 | Shin J, Ramdas A, Rinaldo A | 4 | 4 | 6.5 | 0.017 | 0.928 | 100% | |
| 11 | Neyman J | 1934 | 5 | 2 | 7.0 | 0.021 | 0.874 | 100% |
| 12 | Hu F, Zhang LX | 2004 | 6 | 2 | 9.0 | 0.025 | 0.874 | 100% |
| 13 | Mete B | 2022 | 3 | 3 | 5.0 | 0.012 | 0.843 | 100% |
| 14 | Slivkins A | 2019 | 3 | 3 | 4.5 | 0.012 | 0.843 | 100% |
| 15 | Hirano K, Porter JR | 2023 | 3 | 3 | 4.5 | 0.012 | 0.843 | 100% |
| 16 | Nie X, Tian X, Taylor J, Zou J | 2018 | 3 | 3 | 4.5 | 0.012 | 0.843 | 100% |
| 17 | Offer-Westort M, Coppock A, Green DP | 2021 | 3 | 3 | 4.5 | 0.012 | 0.843 | 100% |
| 18 | Shin J, Ramdas A, Rinaldo A | 3 | 3 | 4.5 | 0.012 | 0.843 | 100% | |
| 19 | Zhang K, Janson L, Murphy S | 2020 | 3 | 3 | 4.5 | 0.012 | 0.843 | 100% |
| 20 | Zhang K, Janson L, Murphy S | 2021 | 3 | 3 | 4.5 | 0.012 | 0.843 | 100% |
| 21 | Imbens GW, Rubin DB | 2015 | 3 | 2 | 4.0 | 0.012 | 0.737 | 100% |
| 22 | Li HH, Owen AB | 2024 | 3 | 2 | 4.5 | 0.012 | 0.737 | 100% |
| 23 | Brown BM | 1971 | 3 | 2 | 6.0 | 0.012 | 0.737 | 100% |
| 24 | Armstrong TB | 2022 | 2 | 2 | 1.5 | 0.008 | 0.644 | 100% |
| 25 | Russac Y, Katsimerou C, Bohle D, Cappe O, Garivier... | 2021 | 2 | 2 | 2.5 | 0.008 | 0.644 | 100% |
| 26 | Lai TL, Robbins H | 1985 | 2 | 2 | 2.5 | 0.008 | 0.644 | 100% |
| 27 | Robbins H | 1952 | 2 | 2 | 2.5 | 0.008 | 0.644 | 100% |
| 28 | Bowden J, Trippa L | 2017 | 2 | 2 | 2.5 | 0.008 | 0.644 | 100% |
| 29 | Hadad V, Hirshberg DA, Zhan R, Wager S, Athey S | 2021 | 2 | 2 | 2.5 | 0.008 | 0.644 | 100% |
| 30 | Zhan R, Hadad V, Hirshberg DA, Athey S | 2021 | 2 | 2 | 2.5 | 0.008 | 0.644 | 100% |
| 31 | Zhan R, Ren Z, Athey S, Zhou Z | 2023 | 2 | 2 | 2.5 | 0.008 | 0.644 | 100% |
| 32 | Perchet V, Rigollet P, Chassang S, Snowberg E | 2016 | 2 | 2 | 4.0 | 0.008 | 0.644 | 100% |
| 33 | Ross SM | 2013 | 2 | 2 | 3.0 | 0.008 | 0.644 | 100% |
| 34 | Aznag A, Cummings R, Elmachtoub AN | 2023 | 2 | 1 | 1.0 | 0.008 | 0.511 | 100% |
| 35 | Adusumilli K | 2022 | 2 | 1 | 1.0 | 0.008 | 0.511 | 100% |
| 36 | Kato M, Ariu K, Imaizumi M, Uehara M, Nomura M, Qi... | 2022 | 2 | 1 | 1.0 | 0.008 | 0.511 | 100% |
| 37 | Wu CF | 1981 | 2 | 1 | 4.0 | 0.008 | 0.511 | 100% |
| 38 | Gut A | 2009 | 2 | 1 | 4.0 | 0.008 | 0.511 | 100% |
| 39 | Cox DR, Reid N | 2000 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 40 | Fisher RA | 1936 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 41 | Wu CJ, Hamada MS | 2011 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 42 | Cook TD, Campbell DT, Shadish W | 2002 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 43 | Deaton A, Cartwright N | 2018 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 44 | Duflo E, Glennerster R, Kremer M | 2007 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 45 | Karlan DS, Zinman J | 2008 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 46 | Mosleh M, Martel C, Eckles D, Rand DG | 2021 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 47 | Berry DA | 2006 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 48 | Hu F, Rosenberger WF | 2003 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 49 | Rosenberger WF, Lachin JM | 2015 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 50 | Rossi PE, Allenby GM | 2003 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 51 | Sandor Z, Wedel M | 2001 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 52 | Bakshy E, Eckles D, Bernstein MS | 2014 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 53 | Deng A, Xu Y, Kohavi R, Walker T | 2013 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 54 | Kohavi R, Longbotham R | 2017 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 55 | Hahn J | 1998 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 56 | Hirano K, Imbens GW, Ridder G | 2003 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 57 | Robins JM, Rotnitzky A, Zhao LP | 1994 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 58 | Robins JM, Rotnitzky A | 1995 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 59 | Scharfstein DO, Rotnitzky A, Robins JM | 1999 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 60 | Ding P | 2024 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 61 | Wager S | 2024 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 62 | Etore P, Jourdain B | 2010 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 63 | Etore P, Fort G, Jourdain B, Moulines E | 2011 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 64 | Dai J, Gradu P, Harshaw C | 2023 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 65 | Chen X, Jasin S, Shi C | 2022 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 66 | Russo DJ, Van Roy B, Kazerouni A, Osband I, Wen Z,... | 2018 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 67 | Agrawal S, Goyal N | 2012 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 68 | Audibert JY, Munos R, Szepesvari C | 2009 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 69 | Auer P, Cesa-Bianchi N, Fischer P | 2002 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 70 | Garivier A, Cappe O | 2011 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 71 | Russo D, Van Roy B | 2016 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 72 | Simchi-Levi D, Wang C | 2023 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 73 | Thompson WR | 1933 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 74 | Hu F, Rosenberger WF | 2006 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 75 | Jennison C, Turnbull BW | 1999 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 76 | Sverdlov O | 2015 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 77 | Efron B | 1971 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 78 | Wei L | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% | |
| 79 | Wei L | 1979 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 80 | Eisele JR | 1990 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 81 | Eisele JR | 1994 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 82 | Eisele JR, Woodroofe MB | 1995 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 83 | Wei LJ | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% | |
| 84 | Azriel D, Feigin PD | 2014 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 85 | Melfi V, Page C | 1998 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 86 | Rosenberger WF, Stallard N, Ivanova A, Harper CN, ... | 2001 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 87 | Blackwell M, Pashley NE, Valentino D | 2022 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 88 | Cai Y, Rafi A | 2024 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 89 | Cytrynbaum M | 2021 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 90 | Tabord-Meehan M | 2023 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 91 | Wei W, Ma X, Wang J | 2025 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 92 | Deshpande Y, Mackey L, Syrgkanis V, Taddy M | 2018 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 93 | Deshpande Y, Javanmard A, Mehrabi M | 2019 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 94 | Bechhofer RE | 1954 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 95 | Chick SE, Inoue K | 2001 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 96 | Glynn P, Juneja S | 2004 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 97 | Hong LJ, Fan W, Luo J | 2021 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 98 | Hunter SR, Nelson BL | 2017 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 99 | Chen CH | 1996 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 100 | Chen CH, Lin J, Yucesan E, Chick SE | 2000 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 101 | Audibert JY, Bubeck S, Munos R | 2010 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 102 | Kasy M, Sautmann A | 2021 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 103 | Mannor S, Tsitsiklis JN | 2004 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 104 | Russo D | 2016 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 105 | Wager S, Xu K | 2021 | 1 | 1 | 0.5 | 0.004 | 0.406 | 100% |
| 106 | Rubin DB | 1974 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 107 | Holland PW | 1986 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 108 | Abadie A, Athey S, Imbens GW, Wooldridge JM | 2020 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 109 | Borodin A, El-Yaniv R | 2005 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 110 | Buchbinder N, Naor JS, et al | 2009 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 111 | Berger JO | 2013 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 112 | Bickel PJ, Doksum KA | 2015 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 113 | Li KC | 1983 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 114 | Manski CF | 2004 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 115 | Stoye J | 2009 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 116 | Bojinov I, Simchi-Levi D, Zhao J | 2023 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 117 | Ni T, Bojinov I, Zhao J | 2023 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 118 | Bai Y | 2023 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 119 | Basse GW, Ding Y, Toulis P | 2023 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 120 | Bai Y | 2022 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 121 | Candogan O, Chen C, Niazadeh R | 2021 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 122 | Greevy R, Lu B, Silber JH, Rosenbaum P | 2004 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 123 | Harshaw C, Savje F, Spielman D, Zhang P | 2019 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 124 | Lu B, Greevy R, Xu X, Beck C | 2011 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 125 | Rosenbaum PR | 1989 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 126 | Zhao J, Zhou Z | 2022 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 127 | Gibson E, Deo S, Jonasson JO, Kachule M, Palamount... | 2023 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 128 | Abadie A, Zhao J | 2021 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 129 | Doudchenko N, Khosravi K, Pouget-Abadie J, Lahaie ... | 2021 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 130 | Asmussen S, Glynn PW | 2007 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 131 | Glasserman P | 2004 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 132 | Fan L, Glynn PW | 2024 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 133 | Kalvit A, Zeevi A | 2021 | 1 | 1 | 1.0 | 0.004 | 0.406 | 100% |
| 134 | Boucheron S, Lugosi G, Massart P | 2013 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 135 | McDiarmid C, et al | 1989 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 136 | Badanidiyuru A, Kleinberg R, Slivkins A | 2018 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 137 | Arlotto A, Gurvich I | 2019 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |
| 138 | Bretagnolle J, Huber C | 1979 | 1 | 1 | 2.0 | 0.004 | 0.406 | 100% |